UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009297
Receipt No. R000010909
Scientific Title Randomized phase II study comparing trastuzumab plus weekly paclitaxel with weekly paclitaxel alone for patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.
Date of disclosure of the study information 2012/11/09
Last modified on 2018/11/15 10:08:20

No. Disposal Last modified on Item of update
1 Insert 2012/11/09 13:21:46
2 Update 2013/01/30 10:00:24 Recruitment status
3 Update 2013/01/30 10:01:52 Public title
4 Update 2013/01/30 10:05:06 Condition
Narrative objectives1
Key secondary outcomes
5 Update 2013/01/30 10:10:38 Key inclusion criteria
Key exclusion criteria
6 Update 2016/07/28 09:47:44 Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary sponsor
Organization
Organization
Organization
Category of Funding Organization
7 Update 2017/01/10 10:01:15 Recruitment status
8 Update 2018/05/15 11:28:04 Organization
9 Update 2018/11/15 10:08:20 Recruitment status
Publication of results


Contact us.